(Q50509685)

14 March 2018

title

In vitro antimycobacterial activities of Physalis angulata L. (English)

1 reference

14 March 2018

1 reference

Physalis angulata

1 reference

Pietro RC

1

1 reference

14 March 2018

Kashima S

2

1 reference

14 March 2018

Sato DN

3

1 reference

14 March 2018

Januário AH

4

1 reference

14 March 2018

França SC

5

1 reference

14 March 2018

publication date

1 July 2000

1 reference

14 March 2018

published in

Phytomedicine

1 reference

14 March 2018

volume

7

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

335-338

1 reference

14 March 2018

Phygrine, an alkaloid from Physalis species

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Antimycobacterial crude plant extracts from South, Central, and North America

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

In vitro activities of 2,2'-bipyridyl analogues against Mycobacterium avium and M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Evaluation of African medicinal plants for their in vitro trypanocidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

A New physalin from Physalis alkekengi: structure of physalin L

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Physalins N and O from Physalis alkekengi

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Immunomodulatory activity of various fractions derived from Physalis angulata L extract

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Physalin and neophysalins from Physalis alkekengi var. francheti and their differentiation inducing activity

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Use of a colorimetric system for yeast susceptibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

In vitro antimycobacterial activities of pyrazinamide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2800%2980052-5

7 January 2021

10.1016/S0944-7113(00)80052-5

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018